Neurogene Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Neurogene Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2013 to Q4 2023.
  • Neurogene Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $98.9M, a 159% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $98.9M +$60.8M +159% Dec 31, 2023 10-K 2024-03-18
Q4 2022 $38.2M +$13M +51.5% Dec 31, 2022 10-K 2024-03-18
Q4 2021 $25.2M +$10.3M +69.2% Dec 31, 2021 10-K 2024-03-18
Q4 2020 $14.9M -$42.9M -74.2% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $57.8M +$590K +1.03% Dec 31, 2019 10-K 2021-03-25
Q4 2018 $57.2M +$7.83M +15.8% Dec 31, 2018 10-K 2020-03-12
Q4 2017 $49.4M +$12.7M +34.8% Dec 31, 2017 10-K 2019-03-07
Q4 2016 $36.7M +$10.5M +40.2% Dec 31, 2016 10-K 2018-03-12
Q4 2015 $26.1M +$5.53M +26.8% Dec 31, 2015 10-K 2017-03-09
Q4 2014 $20.6M +$4.52M +28.1% Dec 31, 2014 10-K 2016-03-14
Q4 2013 $16.1M Dec 31, 2013 10-K 2015-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.